Feedback / Questions
Bavencio (avelumab) - EMD Serono, Pfizer
AVA04-VbP - Avacta
https://www.businesswire.com/news/home/20200128005454/en/Avacta%E2%80%99s-Proprietary-TMAC-Cancer-Therapy-Platform-Demonstrates
Jan 28, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next